BioSpace News Archive

SPN-812 (viloxazine hydrochloride), a once-daily novel serotonin norepinephrine modulating agent (SNMA), demonstrates a reduction in ADHD-RS-5 total score as early as Week 1 and continuing until the end of the pivotal clinical studies

Dr. Amir Bajoghli of the Skin and Laser Surgery Center added to the wealth of knowledge of the medical community with his presentation of two medical papers at the largest European dermatology meeting.

Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, will present a poster at the 2020 American Society of Clinical Oncology’s Gastrointestinal Cancers Symposium being held from January 23-25, 2020 at the Moscone West Building in San Francisco, CA.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds®' flagship cannabidiol (CBD) product Real Scientific Hemp Oil™ (RSHO™) was featured in popular lifestyle outlet Us Weekly.

INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today that the Company plans to attend the 45th Edition of Arab Health Exhibition and Congress on January 27-30, 2020 at the Dubai World Trade Centre in Dubai, UAE.

Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announces today the signing of a Master Sales Agreement with iBrands Corporation to distribute the nutraceutical line of products developed by TSOI for sales through its iBrands Farms subsidiary.

Industry leader to present the market with a one-stop, single-vendor solution for medical image capture, management, storage, and image enablement

BrainStorm Cell Therapeutics Inc.(NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that Ralph Kern, MD, MHSc, Chief Operating Officer and Chief Medical Officer, will present at the 10th Annual California ALS Research Summit, January 24-25 at Cedars-Sinai Medical Center, Los Angeles, California.

Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced it will host an Investor and Analyst Day on Wednesday, January 29, 2020 in New York City.

GENYOUth, a leading national youth health and wellness nonprofit dedicated to creating healthier school communities, announced today the recent appointment of two new members to its board of directors.